The emerging therapy of this peptide represents a significant development in the management of diabetes mellitus type 2. Different to existing therapies, tirzepatide affects two pathways – the GLP-1 hormone and https://tirzepatide-peptide646263.blogdemls.com/41819504/tirzepatide-peptide-a-new-frontier-in-diabetes-treatment